Tetsuwan Scientific
Generated 5/3/2026
Executive Summary
Tetsuwan Scientific, founded in 2020 and based in San Francisco, is pioneering the automation of life science research through its AI-powered platform, ResearchOS. The software translates natural language or document inputs into executable protocols for laboratory robots, democratizing access to automation and enabling scientists to focus on knowledge-driven exploration rather than repetitive manual tasks. By lowering the barrier to lab automation, Tetsuwan Scientific aims to accelerate discoveries in drug development and biotechnology, ultimately fostering cloud-based research laboratories that can operate remotely and scale efficiently. The company's technology addresses the growing need for reproducible and efficient experimentation in an era of increasing data complexity and research costs. With its innovative approach, Tetsuwan Scientific is positioned to transform how life science research is conducted, making it faster, more flexible, and more accessible to a broader range of institutions.
Upcoming Catalysts (preview)
- Q3 2026Launch of ResearchOS 2.0 with enhanced language support and new integrations70% success
- Q4 2026Strategic partnership with a top-20 pharmaceutical company for pilot deployment50% success
- Q2 2026Series A funding round to accelerate product development and sales80% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)